These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8538922)

  • 1. Effect of isradipine on renal haemodynamics and systemic blood pressure changes induced by intravenous infusion of endothelin in healthy humans.
    Sørensen SS; Jensen JD; Madsen JK; Pedersen EB
    Nephrol Dial Transplant; 1995; 10(8):1324-31. PubMed ID: 8538922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
    Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
    Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
    Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
    Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
    Dhaun N; Ferro CJ; Davenport AP; Haynes WG; Goddard J; Webb DJ
    Nephrol Dial Transplant; 2007 Nov; 22(11):3228-34. PubMed ID: 17556408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2.
    Geertsen PF; von der Maase H; Olsen NV; Fogh-Andersen N; Nielsen SL; Leyssac PP
    Clin Sci (Lond); 1998 Jul; 95(1):73-81. PubMed ID: 9662488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of nifedipine with the renovascular effects of endothelin in humans.
    Kaasjager KA; van Rijn HJ; Koomans HA; Rabelink TJ
    J Pharmacol Exp Ther; 1995 Oct; 275(1):306-11. PubMed ID: 7562563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism.
    Francischetti EA; Barroso I; da Silva A; Fagundes VG
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined actions of isradipine and captopril on renal function in hypertension.
    Krusell LR; Sihm I; Jespersen LT; Thomsen K; Pedersen EB; Pedersen OL
    J Hum Hypertens; 1992 Oct; 6(5):401-7. PubMed ID: 1464898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dihydralazine on renal water and aquaporin-2 excretion in humans.
    Vase H; Lauridsen TG; Bech JN; Pedersen EB
    Scand J Clin Lab Invest; 2009; 69(1):45-51. PubMed ID: 18728933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and femoral vascular responses to endothelin-1 in dogs: role of prostaglandins.
    Miura K; Yukimura T; Yamashita Y; Shimmen T; Okumura M; Yamanaka S; Imanishi M; Yamamoto K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):11-7. PubMed ID: 1988651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans.
    Vuurmans JL; Boer P; Koomans HA
    Nephrol Dial Transplant; 2004 Nov; 19(11):2742-6. PubMed ID: 15328386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study.
    van Riemsdijk IC; Mulder PG; de Fijter JW; Bruijn JA; van Hooff JP; Hoitsma AJ; Tegzess AM; Weimar W
    Transplantation; 2000 Jul; 70(1):122-6. PubMed ID: 10919587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
    Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F
    Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sarafotoxin S6c on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
    Matsuo G; Matsumura Y; Tadano K; Morimoto S
    J Pharmacol Exp Ther; 1997 Feb; 280(2):905-10. PubMed ID: 9023305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of the new calcium channel blocking drug isradipine.
    Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
    Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers.
    Sørensen SS; Madsen JK; Pedersen EB
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F411-8. PubMed ID: 8160789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects.
    Schmetterer L; Dallinger S; Bobr B; Selenko N; Eichler HG; Wolzt M
    Br J Pharmacol; 1998 Jul; 124(5):930-4. PubMed ID: 9692778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.